Novel model combining contrast-enhanced ultrasound with serology predicts hepatocellular carcinoma recurrence after hepatectomy

doi:10.12998/wjcc.v9.i24.7009

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 24

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3847)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

178

WORD

182

HTML

1738

Figures (1-6)

237

Tables (1-2)

264

Sum=2599

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

422

Download

826

Sum=1248

Aug 26, 2021 (publication date) through Oct 2, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Aug 26, 2021; 9(24): 7009-7021
Published online Aug 26, 2021. doi: 10.12998/wjcc.v9.i24.7009

Full Size Figure Download Figure

Figure 5 Kaplan–Meier curves for survival at 6 mo (A), 12 mo (B), and 24 mo (C). RFS: Relapse free survival.

Citation: Tu HB, Chen LH, Huang YJ, Feng SY, Lin JL, Zeng YY. Novel model combining contrast-enhanced ultrasound with serology predicts hepatocellular carcinoma recurrence after hepatectomy. World J Clin Cases 2021; 9(24): 7009-7021
URL: https://www.wjgnet.com/2307-8960/full/v9/i24/7009.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i24.7009